This segment encompasses the research, development, and clinical trials of new pharmaceutical products. Hisun's R&D efforts focus on various therapeutic areas, including oncology, cardiovascular diseases, and infectious diseases. The company utilizes advanced technologies such as small molecule drug development and monoclonal antibody research. This segment is crucial for expanding Hisun's product pipeline and addressing unmet medical needs. The company has multiple R&D sites located in Taizhou, Beijing, and Shanghai. The patient impact is significant, as successful drug development leads to improved treatment options and outcomes. Hisun aims to maintain a strong market position through continuous innovation and strategic partnerships. Future opportunities include expanding into new therapeutic areas and leveraging cutting-edge technologies. Regulatory and clinical aspects are managed through rigorous testing and adherence to global standards. Partnerships with research institutions and other pharmaceutical companies are key to accelerating the development process.

This segment focuses on the manufacturing and commercialization of pharmaceutical products. Hisun operates multiple manufacturing facilities, including those in Taizhou, Fuyang, and Nantong, ensuring a robust supply chain. The company manufactures a wide range of products, including active pharmaceutical ingredients (APIs) and finished dosage forms. The therapeutic areas covered include anti-tumor, cardiovascular, and anti-infective drugs. The company's manufacturing processes adhere to strict quality control standards to ensure product safety and efficacy. Hisun's market positioning is strengthened by its ability to produce both generic and specialty drugs. Future growth opportunities include expanding manufacturing capacity and entering new markets. Regulatory compliance is a key aspect of this segment, with adherence to GMP (Good Manufacturing Practice) and other relevant regulations. The company also provides contract manufacturing services.

Hisun's contract manufacturing services division provides comprehensive manufacturing solutions for pharmaceutical companies. This segment offers a wide range of services, including formulation development, manufacturing, packaging, and quality control. The company's facilities are equipped to handle various dosage forms, including oral solid dosage and injectables. The therapeutic areas supported by contract manufacturing include a broad spectrum of pharmaceutical products. The patient impact is realized through the production of high-quality medicines for various diseases. Hisun's market positioning in this segment is enhanced by its advanced manufacturing capabilities and adherence to regulatory standards. Future opportunities include expanding the range of services offered and attracting new clients. Regulatory compliance is a critical aspect, with adherence to GMP and other relevant guidelines. Partnerships with other pharmaceutical companies are essential for providing comprehensive manufacturing solutions.